26 December 2024 : Clinical Research
Predictive Power of Anthropometric Measures and Indices in Assessing Nutrition-Related Risk Using the Geriatric Nutritional Risk Index in Elderly Patients: A Cross-Sectional Study
Justyna Nowak
ABCDEFG 1*, Marzena Jabczyk E 2, Michał Skrzypek C 3, Katarzyna Brukało F 4, Bartosz Hudzik C 5,6, Barbara Zubelewicz-Szkodzinska E 2,7
DOI: 10.12659/MSM.946316
Med Sci Monit 2024; 30:e946316
Table 2 Baseline clinical and laboratory characteristics (N=185).
| No nutrition-related risk group (n=137) | Nutrition-related risk group (n=48) | P | |
|---|---|---|---|
| Age (years) | 79 (74–83) | 82 (77.5–85) | 0.0031a |
| Sex, women n (%) | 95 (69.3) | 34 (70.8) | 0.8467b |
| Length of hospitalization (days) | 10 (8–13) | 11 (8–15.5) | 0.058a |
| Heart failure, n (%) | 52 (38.0) | 15 (31.3) | 0.4055b |
| Coronary artery disease, n (%) | 51 (37.2) | 12 (25.0) | 0.124b |
| Prior myocardial infarction, n (%) | 14 (10.2) | 1 (2.1) | 0.1208c |
| Atrial fibrillation, n (%) | 26 (19.0) | 11 (22.9) | 0.5572b |
| Arterial hypertension, n (%) | 114 (83.2) | 38 (79.2) | 0.5287b |
| Stroke, n (%) | 18 (13.1) | 6 (12.5) | 0.9098b |
| Alzheimer’s disease, n (%) | 13 (9.5) | 9 (18.8) | 0.0881b |
| Dementia, n (%) | 26 (19.0) | 11 (22.9) | 0.5572b |
| Depression, n (%) | 16 (11.7) | 4 (8.3) | 0.6013c |
| Chronic obstructive pulmonary disease, n (%) | 13 (9.5) | 2 (4.2) | 0.3608c |
| Chronic kidney disease (stage 3 or below), n (%) | 19 (13.9) | 7 (14.6) | 0.9024b |
| Diabetes mellitus, n (%) | 56 (40.9) | 8 (16.7) | 0.0024b |
| Hypothyroidism, n (%) | 16 (11.7) | 9 (18.8) | 0.2175b |
| Osteoporosis, n (%) | 8 (5.8) | 9 (18.8) | 0.0077b |
| Anemia, n (%) | 33 (24.1) | 17 (35.4) | 0.1283b |
| Albumin (g/L) | 37 (35–39) | 34 (31.5–35) | <0.0001a |
| Vitamin D (nmol/L) | 32.1 (26.9–43.4) | 30.5 (21.5–42.7) | 0.5243a |
| Thyroid-stimulating hormone (uIU/mL) | 1.4 (0.8–2.1) | 1.2 (0.8–2.2) | 0.6312a |
| Fasting glucose (mmol/L) | 5.4 (4.9–6.3) | 5.1 (4.6–5.7) | 0.0944a |
| Total cholesterol (mmol/L) | 4.9 (±1.1) | 4.4 (±1.0) | 0.0153d |
| LDL cholesterol (mmol/L) | 2.7 (2.2–3.5) | 2.7 (1.9–3.3) | 0.2623a |
| HDL cholesterol (mmol/L) | 1.4 (1.1–1.7) | 1.5 (1.1–1.8) | 0.8145a |
| Non-HDL cholesterol (mmol/L) | 3.4 (±1.1) | 3.0 (±1.0) | 0.02d |
| Triglycerides (mmol/L) | 1.3 (0.9–1.6) | 1.0 (0.8–1.2) | <0.0001a |
| C-reactive protein | 1.8 (0.7–4.6) | 2.5 (0.7–6.6) | 0.2578a |
| eGFR (mL/min/1.73 m) | 69 (59–83) | 81 (62–90) | 0.0285a |
| Serum creatinine (μmol/L) | 76 (65.4–87.5) | 65.4 (56.6–87.5) | 0.0295a |
| Aspartate aminotransferase (U/L) | 18 (14–22) | 16 (13.5–20) | 0.0697a |
| Alanine aminotransferase (U/L) | 16 (13–22) | 13 (10–18.5) | 0.0053a |
| Gamma-glutamyltransferase (U/L) | 24 (16–36) | 20 (15–34) | 0.302a |
| a U Mann-Whitney test; b Chi-squared test; c Fisher test; d test. | |||